Charles Reinhold, is a
Pathology - Cytopathology physician based in Hilo, Hawaii. Charles Reinhold is licensed to practice in Hawaii (license number MD6657) and his current practice location is 1190 Waianuenue Ave, Hilo, Hawaii. He can be reached at his office (for appointments etc.) via phone at
(808) 974-6898.
NPI number for Charles Reinhold is 1689753709 and his current mailing address is 1190 Waianuenue Ave, Hilo, Hawaii. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1689753709.
Physician's Profile
| Full Name | Charles Reinhold |
|---|
| Gender | Male |
|---|
| Speciality | Pathology - Cytopathology |
|---|
| Location | 1190 Waianuenue Ave, Hilo, Hawaii |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1689753709
- Provider Enumeration Date: 11/02/2006
- Last Update Date: 09/11/2025
Medical Identifiers
Medical identifiers for Charles Reinhold such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1689753709 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 207ZC0500X | Pathology - Cytopathology | MD6657 (Hawaii) | Primary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD6657 (Hawaii) | Secondary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Charles Reinhold is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Charles Reinhold, 1190 Waianuenue Ave, Hilo, HI 96720-2020 Ph: Not Available | Charles Reinhold, 1190 Waianuenue Ave, Hilo, HI 96720-2020 Ph: (808) 974-6898 |
Reviews and Comments